Expand All Collapse All
IID-8
Increase the percentage of children aged 19 to 35 months who receive the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella and pneumococcal conjugate vaccine (PCV)
LHI
Leading Health Indicators are a subset of Healthy People 2020 objectives selected to communicate high-priority health issues.
Leading Health Indicators are a subset of Healthy People 2020 objectives selected to communicate high-priority health issues.
About the Data: National
Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Number of children aged 19 to 35 months receiving at least four doses of diphtheria-tetanus-acellular pertussis (DTaP), at least three doses of polio, at least one dose of measles-containing vaccine, at least three or four doses of Haemophilus influenzae B (Hib) depending on the brand used, at least three doses of hepatitis B antigens, at least one dose of varicella, and at least four doses of PCV
Number of children aged 19 to 35 months
From the 2013 National Immunization Survey Provider-Immunization History Questionnaire:
[NUMERATOR:]
Specify month, day, and year that each vaccine was given, either by the office or another provider, and type of vaccine, as documented in the records.
The National Immunization Survey (NIS) uses a quarterly, random-digit-dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data are weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys include landline and cellular telephone households.
This measure tracks the proportion of children aged 19 to 35 months receiving the routine series of recommended vaccinations, referred to as 4:3:1:3:3:1:4 series. This series includes at least four doses of diphtheria-tetanus-acellular pertussis (DTaP), at least three doses of polio, at least one dose of measles-containing vaccine, at least three or four doses of Haemophilus influenzae B (Hib) vaccine depending on the brand used, at least three doses of hepatitis B, at least one dose of varicella antigens, and at least 4 doses of pneumococcal conjugate vaccine (PCV). The number of Hib vaccine doses required differs according to manufacturer (brand). This measure does take into account the brand of vaccine used and assumes that doses with missing Hib type/brand information are a type requiring 4 doses to be up-to-date.
About the Data: State
Description of the data source, numerator, denominator, survey questions, and other relevant details about the state-level data.
Number of children aged 19 to 35 months receiving at least four doses of diphtheria-tetanus-acellular pertussis (DTaP), at least three doses of polio, at least one dose of measles-containing vaccine, at least three or four doses of Haemophilus influenzae B (Hib) depending on the brand used, at least three doses of hepatitis B antigens, at least one dose of varicella, and at least four doses of PCV
Number of children aged 19 to 35 months
From the 2013 National Immunization Survey Provider-Immunization History Questionnaire:
[NUMERATOR:]
Specify month, day, and year that each vaccine was given, either by the office or another provider, and type of vaccine, as documented in the records.
The National Immunization Survey (NIS) uses a quarterly, random-digit-dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data are weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys include landline and cellular telephone households.
This measure tracks the proportion of children aged 19 to 35 months receiving the routine series of recommended vaccinations, referred to as 4:3:1:3:3:1:4 series. This series includes at least four doses of diphtheria-tetanus-acellular pertussis (DTaP), at least three doses of polio, at least one dose of measles-containing vaccine, at least three or four doses of Haemophilus influenzae B (Hib) vaccine depending on the brand used, at least three doses of hepatitis B, at least one dose of varicella antigens, and at least 4 doses of pneumococcal conjugate vaccine (PCV). The number of Hib vaccine doses required differs according to manufacturer (brand). This measure does take into account the brand of vaccine used and assumes that doses with missing Hib type/brand information are a type requiring 4 doses to be up-to-date.
Revision History
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
References
Additional resources about the objective
- CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163.
- CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177.
- CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696.